Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ATNX - Athenex Inc

Close
0.2031
-0.062   -30.527%

Share volume: 0
Last Updated: Wed 24 May 2023 10:00:00 PM CEST
Pharmaceutical Preparation Manufacturing : -2.88%

PREVIOUS CLOSE
CHG
CHG%
$0.27
-0.06
-23.39%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-03-31 2022-06-30 2022-09-30 2022-12-31
Fiscal Quarter Q1 2022 Q2 2022 Q3 2022 Q4 2022
Report Date 2022-05-10 2022-07-29 2022-11-03 2023-03-20
Total revenue 29.724 M 31.516 M 33.530 M 8.051 M
Cost of revenue 23.295 M 23.092 M 27.736 M 1.995 M
Gross profit 6.429 M 8.424 M 5.794 M 6.056 M
    31.03% -31.22% 4.52%  
Operating expenses 28.925 M 30.266 M 18.652 M 18.795 M
Selling general and admin 14.935 M 17.172 M 9.438 M 3.335 M
Research and development 13.990 M 13.094 M 9.214 M 15.460 M
Total expenses 52.220 M 53.358 M 46.388 M 20.790 M
    2.18% -13.06% -55.18%  
Operating income -22.496 M -21.842 M -12.858 M -12.739 M
Ebit -22.496 M -21.842 M -12.858 M -12.739 M
Pretax income -30.441 M -24.052 M -19.020 M -25.115 M
    -20.99% -20.92% 32.05%  
Income tax 28.000 K -19.000 K 596.000 K -258.000 K
Net income basic -17.420 M -32.157 M -19.669 M -34.181 M
    -84.60% 38.83% -73.78%  
Net income -17.420 M -32.157 M -19.669 M -34.181 M
    -84.60% 38.83% -73.78%